Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

RMJ. 2023; 48(3): 548-552


Acute limb ischemia associated with COVID-19 in Basra province, Iraq

Thamir Fozzie Muhmood, Mohammed Sanaa Alshukoor, Abdulkareem Z. Al-Musawi, Adel Makki Abdulateef.




Abstract

Objective: To investigate acute limb ischemia (ALI) incidence, characteristics, and clinical outcomes at Basra Tertiary Hospital during the COVID-19 Pandemic.
Methodology: This cross-sectional investigation included 53 COVID-19-infected patients with limb ischemia in Al-Sader teaching hospital from April 2020 to May 2022. Each patient's gender, age, smoking status, and medical history like diabetes, hypertension, hypercholesterolemia, and respiratory failure were recorded.
Results: Mean age of patients was 63 ± 8 years. Out of 53 patients, 88.7% were males and most (67.9%) were 60 years old or more. 75.5 of patients were smokers, 50.9%, 39.6%, 22.6%, 28.3% had diabetes mellitus, hypertension, hypercholesterolemia and respiratory failure, respectively. There was a significant association between embolectomy, actylase anticoagulant, death and amputation. 84.6% of patients with embolectomy had amputation while 80% who took actylase anticoagulant had no amputation.
Conclusion: In covid-19 related ALI, amputation was common in embolectomy patients while it was rare in patients who received actylase. Most of deceased patients had amputations.

Key words: COVID-19, acute, limb ischemia, Basra province.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.